drugset / Trial / NCT00162344

A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease.

NCT00162344

Phase 4 Completed 205 enrolled Lantheus Medical Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The study is designed to see if stress heart imaging can be used as a screening exam in patients with diabetes and risk factors of developing of coronary artery disease and experiencing future cardiac events.

Timeline

Start
2003-12
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TECHNETIUM SESTAMIBI Diagnostic / imaging agent

Indications